OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
Microfluidic modulation spectroscopy (MMS) is a novel automated infrared spectroscopic technique with high sensitivity and repeatability. Here, the authors present a series of experimental studies showcasing the performance of MMS in the secondary structure characterization of biopharmaceutical products and compare the MMS results with the conventional Fourier transform infrared data.
for a PDF of the article.
Submitted: Dec. 9, 2019
Accepted: March 9, 2020
Dipanwita Batabyal*, firstname.lastname@example.org, is scientist at Attribute Sciences-Higher Order Structure Group, Amgen, and Mats Wikström*, email@example.com, is principal scientist at Higher Order Structure, BR&C, Attribute Sciences, Amgen. Libo Wang is principal application scientist and Jeffrey Zonderman is chief commercial officer at RedShift Bioanalytics.
*To whom correspondence should be addressed.
Vol. 33, No. 5
When referring to this article, please cite it as F. Mirasol, “Shaping IR Spectroscopy into a Powerful Tool for Biopharma Characterizations,” BioPharm International 33 (5) 2020.